THE 7TH KENYA INTERNATIONAL CANCER CONFERENCE

Conference Theme:
Improving Cancer Outcomes: Innovations, Opportunities & Strategies In The Care Continuum

  • Days
  • Hours
  • Minutes
  • Seconds

Register for virtual attendance

* Physical attendance registration closed.



A word from the KESHO Chair

2022 Conference chair

Dr Miriam Mutebi

Assistant Professor and Breast Surgical Oncologist Aga Khan University Hospital

Greetings from KESHO!

Every 2 years, at the Kenya International Cancer Conference (KICC), the Kenya Society of Haematology and Oncology brings together leading oncology experts, experienced patient advocates, key opinion leaders, policy makers and support staff to discuss key issues in reducing the burden of cancer, saving, and improving the lives of patients.

Our conference this year themed Improving Cancer Outcomes: Innovations, Opportunities & Strategies in the Care Continuum, will showcase the multi-stakeholder, collaborative efforts being made, to ensure tangible results in improving outcomes for cancer patients. The 3-day event happening from 24th to 26th November 2022, will have speakers working across a range of disciplines across the globe showcasing the many significant innovations and strategies in cancer control and management in Kenya and the region along all points in cancer care – from prevention, diagnosis, treatment through to quality of life and end of life care.

The conference will also focus on training, education and mentoring of the next generation of cancer professionals from nursing, medical and clinical oncologists, pediatric, surgical and gynecological oncologists, medical physicists and radiation technicians, palliative care physicians amongst many others. In this time of of unprecedented advance in our knowledge and understanding of the causes of cancer and ways to treat it more effectively using personalized medicine, trainers and trainees have to equip themselves with this new knowledge as quickly as possible to embed these treatments into routine practice. Methods of training have also evolved in recent years.

Our ambitions of reducing the burden of cancer will not bear fruit unless we also focus on strengthening our health systems. Our speakers will highlight work done on policy, implementation and strategies of multisector and multilevel measures aimed at ensuring efficient and effective delivery of preventative, diagnostic, treatment and palliative care services to our patients.

We appreciate the support of all our colleagues and supporters over the years who have been instrumental in the success of our past events and programs. We extend a huge and hearty welcome to you to participate in this years’ international conference.

Preconference Workshops

Radiation Oncology Contouring and Planning Workshop

23rd November 2022

Sarova Whitesands Hotel, Mombasa

The radiation contouring and planning preconference workshop aims at bringing together working teams from the newly established comprehensive centres within Kenya for a day’s immersion into refining radiation clinical skills for two critical and most common cancers in the country. The robust faculty drawn from both local and international centres will offer excellent insights into refining the radiation process and pathways within the new established centres. The outcome of the workshop will be transfer of hands on skills to the new teams and ensure clinical support and linkages are created with the faculty to continue after the conference.

Workshop Registration Fees:

  • No extra charge for those attending the main conference.
  • Ksh 10,000 Single Day Rate applies to those not attending the main conference.

Please note: registration fees include preconference full day attendance, lunch and refreshments

Colorectal Surgery Preceptorship Education & Outreach Summit

22nd – 23 rd November 2022

Sarova Whitesands Hotel, Mombasa and Coast General Training and Referral Hospital

This workshop is run in partnership with the African Organization for Research and Training in Cancer (AORTIC) and the Surgical Society of Kenya (SSK).Colorectal cancer is one of the top five cancers diagnosed in Africa. Many patients are diagnosed with advanced cancers and frequently do not complete their care.One of the major gaps in the workforce is the provision of quality surgical oncology services.The majority of colorectal surgery is performed by general surgeons and there is heterogeneity in training leading to different skill sets in managing cancers. This preconference workshop aims to bring together a multi-disciplinary team of surgeons, gastroenterologists, oncologists, nurses, radiologists, pathologists and palliative care specialists from the region and beyond, to train general surgeons and surgery residents to optimize the holistic management of colorectal cancer. This three-day course will encompass didactic lectures and hands on simulation for colonoscopy, instrument handling etc. culminating in a last day of live surgery and endoscopy.

Workshop Registration Fees:

  • No extra charge for those attending the main conference.
  • Ksh 10,000 Single Day Rate applies to those not attending the main conference.

Please note: registration fees include preconference full day attendance, lunch and refreshments

Abstract Submission Guidelines

Abstracts are invited from Oncologists and other healthcare professionals involved in or with interest in cancer, cancer advocacy groups, healthcare policy and financing agencies.

Subthemes

  1. Research informing Policy and Practice
  2. Training, Education and Mentorship
  3. Improving access to Cancer Care
  4. Advancements in Nursing, Pediatric, Radiation, Medical and Surgical Oncology
  5. Survivorship and Palliative Care
  6. Innovations in Technology and Precision Medicine

Abstract Selection Process

All abstracts will be evaluated and scored by the appropriate Scientific Programme Advisory Working Group members. The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.

The Scientific Committee will determine If accepted as:

  1. An oral presentation
  2. A poster presentation, possibly with a poster session participation or special Scientific Committee mention
  3. A journal publication

The abstract submission deadline has already expired.



A message from the 2022 Scientific Committee

Meet the 2022
Kenya International Cancer Conference Planning Team

2022 Conference Chair
Consultant Medical Oncologist

Dr Sitna Mwanzi

2022 Conference Co-chair
Consultant Clinical Oncologist

Dr Njoki Njiraini

KESHO Chair, Assistant Professor and Consultant Breast Surgical Oncologist

Miriam Mutebi, MD, MMed, MSc, FACS

Consultant Physician and Medical Oncologist

Dr Angela Mcligeyo

Lecturer and Consultant Medical Oncologist

Dr Mohammed Ezzi

Professor of Medicine and Consultant Medical Oncologist

Prof Nicholas Abinya

Consultant Clinical Oncologist

Dr Catherine Nyongesa

CEO, The National Cancer Institute of Kenya

Dr Alfred Karagu

Lecturer/Program Director, Consultant Physician and Medical Oncologist

Dr Andrew Odhiambo

Head of the National Cancer Control Programme Ministry of Health

Dr Mary Nyangasi

Palliative Care Specialist, Technical Advisor, Consultant and Researcher

Dr Zipporah Ali

Lecturer, Consultant Physician and Medical Oncologist

Dr Peter Oyiro

Surgical Oncologist and Consultant Laparoscopic Surgeon

Dr Abdi Hakin Mohamed

Oncology Nurse Specialist & Chair of the Oncology Nurses Chapter

Roselyne Okumu

Vice Chairman of the Non Communicable Diseases Alliance of Kenya (NCD-AK)

David Makumi

Associate Professor of Medicine and Sectional Head of Medical Oncology

Prof Asim Jamal

Paediatric Haematologist Oncologist

Dr Irene Nzamu

Lead, Cancer Prevention, Early Detection & Screening Pillar in the NCCP

Dr JP Bor Malenya

Palliative Care Nurse and Counsellor

Gladys Nduku

Manager, Oncology Department

Dr Fredrick Asige

Consultant Clinical Oncologist

Dr Abeid Athman

Executive Director, Kenya Hospices and Palliative Care Association (KEHPCA)

Mackuline Atieno

Senior Lecturer and Specialist Physician

Dr Naftali Busakhala

Radiation Oncologist

Dr Jesse Opakas

No Results Found

2022 Conference Chair
Consultant Medical Oncologist

Dr Sitna Mwanzi

Dr Sitna Ali Mwanzi is a consultant medical oncologist working at the Kenyatta National Hospital in Nairobi Kenya. She obtained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany. Her research interests include breast cancer, lung cancer, prostate cancer, chronic myeloid leukemia and cervical cancer. She is passionate about increasing health care workers and general public awareness about cancer, role of screening, early diagnosis and treatment of cancer. She works closely with the National Cancer Control Program in implementation of the National Cancer Control Strategy and advising on cancer policy for improving access to cancer care.

2022 Conference Co-chair
Consultant Clinical Oncologist

Dr Njoki Njiraini

Dr. Njoki Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital.

She has been key in instituting multidisciplinary meetings, problem oriented research in the department, and streamlining patient care within the oncology clinics in the public and private sector.

Dr. Njiraini holds a bachelors degree in Medicine and Surgery from the University of Nairobi, a Masters Degree in Radiation Oncology from the University of Cape Town, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme.

KESHO Chair, Assistant Professor and Consultant Breast Surgical Oncologist

Miriam Mutebi, MD, MMed, MSc, FACS

Dr. Miriam Mutebi is a Consultant Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the Aga Khan University Hospital in Nairobi, Kenya. She is also a clinical epidemiologist and health systems researcher with a research focus on understanding barriers to access for women with cancers in Sub-Saharan Africa and in designing interventions to mitigate those barriers.

She is the President Elect of the African Organization for Research and Training in Cancer (AORTIC), the Chairperson for the Kenya Society of Hematology and Oncology (KESHO) and on the board of directors of the Union folr International Cancer Control (UICC). She is also the co-founder of the Pan African Women’s Association of Surgeons (PAWAS-www.africanwomensurgeons.org ) which was developed to mentor and provide transformative leadership for women in surgery in order to improve surgical care and pathology on the continent and is part of the Kenya Association of Women Surgeons.

She is the Co-chair of the National Cancer Taskforce in Kenya, Chair of the Commonwealth Taskforce for the elimination of Cervical Cancer and a commissioner with three Lancet commissions of Women and cancer, Cancer in sub-Saharan Africa and Breast Cancer. She is currently pursuing a pilot's licence in order to extend breast care services to marginalised areas.

Consultant Physician and Medical Oncologist

Dr Angela Mcligeyo

Dr. Angela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi, a M.Sc. in Clinical Oncology from Ulm University (Germany), and a Fellowship in Medical Oncology from the University of Nairobi. In addition, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings.

She is a member of the Kenya Society of Haematology and Oncology (KESHO), European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East, Central and Southern Africa College of Physicians.

Her core skills are in clinical decision making in internal medicine and oncology, conducting trainings, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols.

She currently provides comprehensive oncology healthcare at both public and private health facilities, conducts research in oncology and internal medicine when opportunities arise, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences.

Lecturer and Consultant Medical Oncologist

Dr Mohammed Ezzi

Dr. Mohammed Ezzi is a Lecturer and Consultant Medical Oncologist in the Department of Clinical Medicine and Therapeutics at the University of Nairobi in Nairobi, Kenya. He is also the Treasurer for the Kenya Society of Hematology and Oncology (KESHO) and also the Chair for the Educational subcommittee in the same Society.He did his Internal Medicine residency at the University of Nairobi and subsequently did a two-year fellowship in Medical Oncology at the same university. He is currently a fellow at the College of the European School of Oncology and pursuing a Certificate in Competence in Breast Cancer by the European School of Oncology.

His academic focus is in medical education and is passionate about teaching across the spectrum of medical learners with an interest in enhancing oncologic knowledge amongst non-oncologist. He has presented at several symposia, workshops and conferences both locally and internationally. He has several publications in peer reviewed international journals. Dr. Mohammed Ezzi is a member of KESHO, ASCO, ESMO, AORTIC and KAP. His key areas of interest include breast cancer, malignant hematology and clinical pharmacology.

Professor of Medicine and Consultant Medical Oncologist

Prof Nicholas Abinya

Prof Nicholas Anthony Othieno-Abinya is a Consultant Medical Oncologist at the Nairobi Hospital Cancer Centre. He was formerly Professor of Medicine at the University of Nairobi, Kenya, where he was the director of Medical Oncology Fellowship Program and also the head of Haematology/Oncology at the University of Nairobi and Kenyatta National Hospital, Nairobi. In 2009 and 2010 he was head of oncology at AgaKhan University Hospital, Nairobi.

He holds a Masters degree in Internal Medicine from the University of Nairobi. He completed fellowship in Medical Oncology at the Royal London Hospital (University of London) in 1992, and is a Fellow of the Royal College of Physicians of Edinburgh.

His research interests are in malignant haematology and breast cancer, in which he has published widely in peer-reviewed journals. He also has keen interest in molecular oncology. He has also authored a text book titled Drug Treatment of Haematologic Neoplasms. He has also co-authored cancer booklets, and has written chapters in several books. His latest book titled ‘Shadow in Perpetuity’ by Lambert Publishers was released in December 2019.

Prof Abinya is a member of American Society of Clinical Oncology (ASCO), and served in its International Affairs Committee from 2010-2012; Africa Organization for Research and Training in Cancer (AORTIC), having been Vice Chair for Eastern Africa and was a long time member of Council; and European Society for Medical Oncology (ESMO). He founded Kenya Society of Haematology and Oncology (KESHO), of which he was the first Chair, and is still its Patron. His outstanding academic achievements were profiled in the University of Nairobi magazine,’ Varsity Focus’ of September 2017.

He has received several awards and honours, including Kenya Breast Health Programme Award in appreciation of contribution to success of the Breast Cancer Survivors’ Conference on 11-14 July 2003; Kenya Breast Health Programme Award in recognition for outstanding contribution to the care of women with breast cancer in Kenya; Best Oral Presentation by Established Scientist Award, 2ND KASH Conference, Kenya Medical Research Institute, Nairobi; 2018 Harvard Global Health Catalyst: Distinguished African Ambassador Award.

He is married with four grown-up children, and grandchildren.

Consultant Clinical Oncologist

Dr Catherine Nyongesa

Dr. Catherine Nyongesa Watta is a Clinical/Radiation Oncologist at Texas Cancer Centre Nairobi and Kenyatta National Hospital, with over 10 years of experience in Oncology conducting inpatient and outpatient management of cancer patients. She has a Bachelor’s degree in Medicine and Surgery (University of Nairobi), Master of Medicine in Radiation Oncology (University of the Witwatersrand, South Africa), and a Fellowship (FC Rad Onc) in Radiation Oncology from the College of Radiation Oncologists of South Africa. Among the key organizations, she has been a member of, the American Society of Clinical Oncology (ASCO), Health Professions Council of South Africa, and International Gynecologic Cancer Society.

She has received a number of awards in recognition of her work nationally and globally. These include:

  1. Conquer Cancer Foundation (2011, ASCO Annual Meeting),
  2. IDEA (International Development Education Award- ASCO, 2009)
  3. IGCS (International Gynecologic Cancer Society) Travelling Scholarship Award 2008
  4. Employee excellence award KNH 2007,
  5. MMED dissertation paper passed with distinction 2005 at University of the Witwatersrand, SA.
  6. Best O level and A level student Misikhu Girls High school (St Cecilia)

She is one of the founders of the Texas Cancer Center Nairobi.

She is also the first female radiation oncologist in Kenya.

CEO, The National Cancer Institute of Kenya

Dr Alfred Karagu

Dr Karagu is a public health specialist with over 14 years’ experience in clinical care, health services management, monitoring and evaluation, training and public health research. He holds a Bachelors degree in Medicine and Surgery and a Master of Science in Health Systems Management and is a graduate of the Field Epidemiology and Laboratory Training Programme, a competency-based training by the Ministry of Health and United States Centre for Disease Control.
He has a vast experience in program management in both the infectious and non-communicable disease prevention spheres having worked in the public health sector across the national and county government levels. He currently serves as the Chief Executive Officer of the National Cancer Institute of Kenya, a statutory body established under the Cancer Prevention and Control Act of 2012 to coordinate and regulate cancer prevention and control activities. He is thus spearheading the development of policies, guidelines and standards to enhance access to cancer treatment, quality improvement initiatives for better treatment outcomes and improved cancer data management to inform policy and practice.
Dr. Karagu has a keen interest in health system research with a number of publications in peer-reviewed journals and presentations at local and international conferences. He is passionate about strengthening health systems to respond to the rising burden of non-communicable diseases through innovations and effective partnerships

Lecturer/Program Director, Consultant Physician and Medical Oncologist

Dr Andrew Odhiambo

Dr. Andrew is a Consultant Physician/Medical Oncologist & Program Director/Lecturer (Medical Oncology Fellowship Program) at the University of Nairobi. Dr. Andrew holds a Master’s degree in Internal Medicine from the University of Nairobi. He has attended a preceptorship training in Haematological Oncology & Infectious Diseases from the University of Maryland Marleen & Stewart Greenbaum Cancer Centre in the United States. He later did his Fellowship in Medical Oncology in the United Kingdom and was certified by the Federation of Royal College of Physicians of the United Kingdom as well as the Association of Cancer Physicians and the European Society for Medical Oncology. He is also a Fellow of the Royal College of Physicians of Edinburgh as well as the East, Central & Southern Africa College of Physicians.

He is the outgoing Secretary & former Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr. Andrew is a member of KAP, ASCO, ESMO, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, ASCO & NCCN Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals.

Dr. Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 50 appearances in mainstream local and international TV and print media promoting cancer awareness.

His key areas of sub specialization and interest include Colon cancer, Stomach cancer, Breast Cancer, Pancreatic, Liver & Bile Duct cancer, Cancer or Unknown Primary, Lymphoma as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon, Skin, Lung, Kidney cancers etc. For his full profile, please visit www.drandrewodhiambo.com

Head of the National Cancer Control Programme Ministry of Health

Dr Mary Nyangasi

Dr. Mary Nyangasi is a public health specialist/epidemiologist with interests in Non-Communicable Disease especially Cancer. She earned her medical degree from the University of Nairobi and a Masters in Public Health in Epidemiology and Disease Control from Kenyatta University. She holds postgraduate certificates in Non-Communicable Diseases and Diplomacy from Graduate Institute Geneva and Leadership and Management in Health from the University of Washington.

She has experience spanning over 15 years in clinical practice and public health with 7 years of specialist oncology practice and currently working in the area of cancer control programming and policy. She is a member of the African Cancer Coalition and has contributed to the development of NCCN harmonized guidelines for head and neck cancers as well as the conceptualization and implementation of Chemosafe project in Kenya.

Dr. Nyangasi is the Head of the National Cancer Control Programme in the Ministry of Health within the Department of Non-Communicable Diseases, the arm within the Ministry that coordinates the implementation of cancer control activities on behalf of the Ministry.

Her main interests are in breast, cervical and colorectal cancers prevention and control, research, innovations in public health for strengthening the health systems and implementation science.

She enjoys cooking especially trying out healthy menus, travelling, meeting new people, networking, and sharing ideas. She is also an avid reader.

Dr. Nyagasi mentors women in her community and participates in community awareness and sensitization on health topics of interest.

Palliative Care Specialist, Technical Advisor, Consultant and Researcher

Dr Zipporah Ali

Dr. Zipporah Ali has recently retired from the position of Executive Director of Kenya Hospices and Palliative Care Association (KEHPCA), a position she held for 15 years. She serves on the board of several organizations including; Kenya Hospices and Palliative Care Association, International Children’s Palliative Care Network (ICPCN), City Cancer Challenge, Alzheimer/Dementia Kenya, Public Health and Palliative Care International, and Kenya Network of Cancer Organizations (KENCO). She has previously served on several other global, regional, and national boards.

Dr. Ali has been and continues to be involved in advocacy and creating awareness on pain relief and palliative care in Kenya for children and adults as well as Universal Health Coverage. In her leadership role as the Executive Director for KEHPCA, she was very instrumental in fostering strong relationships with the Ministry of Health to integrate palliative care into government hospitals. She was also instrumental in advocating for palliative care to be included in the undergraduate medical and nursing schools in Kenya. She is a strong advocate for cancer prevention, control, and treatment and was instrumental in developing the first National Cancer Control Strategy and the National Guidelines for Cancer Management-Kenya. She has also advocated for palliative care to be integrated into other non-communicable diseases as well as infectious diseases.

Dr. Ali has been involved in a number of activities at the World Health Assembly (Geneva) and the UN High-Level Meetings on Non-communicable diseases. She is a strong advocate for the right to health for all and a supporter of the movement on meaningful involvement of persons living with serious health conditions and leaving no one behind.

Dr. Ali holds an MD from Ege University, Izmir, Turkey, a Master’s Degree in Public Health from the University of Nairobi, a Higher Diploma in Palliative Care from Oxford Brookes University, and a Masters in Palliative Care from the University of Dundee. She has completed the International Pain Policy Fellow program with the International Pain Policy Studies Group (WHO Collaborating Centre for Policy and Communication in Cancer Care, University of Wisconsin) as well as a Higher Diploma in the International Palliative Care Leadership Development Initiative at The Institute of Palliative Medicine at the San Diego Hospice.

She has received a number of awards in recognition of her work nationally and globally. These include:

  1. Doctor of Law Honoris Causa-University of Dundee (2018)
  2. International Humanitarian Award-Women4Africa (2018)
  3. Social Impact Award for the Sub-Saharan Africa region-British Council (2018)
  4. Honorary Doctor of the University by Oxford Brookes University (2012)
  5. Individual Advocacy Award by the African Palliative Care Association and Open Society Foundations (2013
  6. African Palliative Care Award –(In recognition for being on the interim board and later serving on the board for 2 teams) -2007

Lecturer, Consultant Physician and Medical Oncologist

Dr Peter Oyiro

Dr. Oyiro is currently a Lecturer at the Department of Clinical Medicine and Therapeutics-The University of Nairobi. He also a consultant Physician and Medical Oncologist at the Kenyatta National Hospital Teaching and Referral Hospital, Nairobi. He attended his Research Fellowship in Hematological Malignancies at the West Virginia University Cancer Center (2013) and Medical Oncology fellowship at the University of Nairobi (2018).He is a member of Kenya Society of Hematology and Oncology (KESHO), American Society of Clinical Oncologist ( ASCO) and the European Society of Medical Oncologists( ESMO).

Dr. Oyiro main interest is in Research and cancer education particularly in Hematological Malignancies, HIV associated neoplasms and Sickle cell disease as well as newer cancer targeted therapy and immunotherapy.

Surgical Oncologist and Consultant Laparoscopic Surgeon

Dr Abdi Hakin Mohamed

Dr. Abdi Hakin Mohamed did his Surgical Residency at the Aga Khan Hospital, Nairobi and Surgical Oncology Fellowship at the prestigious Memorial Sloan- Kettering Cancer Centre in New York, USA where he was the first ever Clinical Fellow from the African continent. At Memorial Sloan Kettering, he worked with world-renowned colorectal surgeons and was involved in research projects in the institution as well as operating on patients using the most highly advanced surgical equipment, including Robotic Colorectal Surgery for colon and rectal cancer. He has been part of local colorectal cancer trials with his mentor the late Prof Saidi Hassan, and has published the most widely quoted colorectal cancer study in East Africa.

Dr. Mohamed works both in the private sector and public sector. He is the Chair of Surgery at the Aga Khan Hospital in Mombasa, and is currently involved in treating cancer patients who need surgery in Mombasa. He is the coordinator of the fellowship division of the COSECSA (College of Surgeons of East, Central and Southern Africa) surgical training program at Coast General Teaching and Research Hospital which is the largest COSECSA program in East Africa.

Oncology Nurse Specialist & Chair of the Oncology Nurses Chapter

Roselyne Okumu

Ms. Roselyne Okumu is the current Chair of the Oncology Nurses Chapter –Kenya, and a member of, NNAK , AORTIC and Africa Oncology Nurses Network.

Roselyne is an assistant chief nurse at KNH CTC, she has excelled in provision of nursing care to different categories of patients. As an Oncology Nurse Specialist she gives nursing care while managing cancer screening & awareness services, advocacy and research.

Roselyne is involved in training, education and mentorship of students at the local university. She is a trainer of trainers of Chemosafe, a program that is geared towards provision of chemotherapy in a safe manner for the healthcare provider, the patient and the environment.

Roselyne works closely with National Cancer Control program(NCCP) and National Cancer institute (NCI) as an expert and has participated in the formulation of several Cancer strategic documents in partnership with NCI and NCCP (National Cancer Control Strategy 2017-2022, National Cancer Screening guidelines and Cancer treatment protocols. She is also involved in mapping oncology nursing training and education in Africa.

She values integrity, honesty and is passionate about cancer research, education and advocacy

Vice Chairman of the Non Communicable Diseases Alliance of Kenya (NCD-AK)

David Makumi

David Makumi is an award winning cancer control advocate and has worked in cancer control at clinical, advocacy and policy level for over 15 years. He was the first recipient of the International Award for Contribution to Cancer Care from the East African Region by Oncology Nursing Society (ONS-USA) in 2011.

David is the current Chairman of the Kenyan Network of Cancer Organizations,(KENCO) the umbrella body of the cancer civil society groups with over 25 cancer patients associations, Community Based organizations, Non-Governmental Organizations and patient groups. He is also serves as the Vice Chairman of the Non Communicable Diseases Alliance of Kenya (NCD-AK) and sits on several cancer related boards and technical groups.

He has professional interests in low cost models of access to screening and care for non-communicable diseases (NCDs) and clinical ethics.

Associate Professor of Medicine and Sectional Head of Medical Oncology

Prof Asim Jamal

Prof Asim Jamal Shaikh is an Associate Professor, Consultant Medical Oncologist and Division chief of Medical Oncology, Department of Hematology and Oncology, at The Aga Khan university Hospital Nairobi. Dr. Shaikh received his Internal Medicine Residency and Medical Oncology Fellowship training from Pakistan. He is a Fellow of College of Physicians and Surgeons Pakistan in the subjects of internal medicine and medical oncology, and The Royal college of Physicians UK. Prof Shaikh has a Leadership Diploma from Harvard Kennedy School of Executive education USA, and the Graduate School of Media at The Aga Khan University.

He is actively involved in clinical service and research. His focus of clinical practice is in solid tumors. He has published widely and specially recently on genomic and clinical aspects of Kenyan and East African women with breast cancer. He Leads the Kenyan Metastatic breast cancer network (www.kmbcn.org ) in Kenya .

Prof Shaikh is the recipient of several international collaborative grants as clinical investigator for oncology research including the SPARC grant from the UICC. He has laid the foundation of medical oncology fellowship programs at the Aga Khan University in Nairobi, and with his academic interests supervises several master level students to their thesis related to cancer studies.

Paediatric Haematologist Oncologist

Dr Irene Nzamu

Dr. Irene Nzamu is a Pediatric Hematologist Oncologist. She is the Head of the Pediatric Hemato Oncology Unit at the Kenyatta National Hospital.

Dr. Nzamu attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi. She did her Fellowship in Pediatric Hematology & Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital.

She is passionate about offering evidence based, affordable care for children with cancer & blood diseases in our resource limited settings.

Lead, Cancer Prevention, Early Detection & Screening Pillar in the NCCP

Dr JP Bor Malenya

Dr. Malenya is a Public Health Specialist with a special interest in non-communicable diseases (NCDs) and 15 years professional experience in the Kenyan public health sector, including over 10 years in clinical care and hospital management.

She is currently the Lead for the Cancer Prevention, Early Detection & Screening Pillar in the NCCP. Her role involves developing and implementing policies and programs towards the achievement of the National Cancer Control Strategy. She coordinated the development of the National Cancer Screening Guidelines in 2018, and is keen to see through the advancement of a harmonized cancer screening program nationwide. She also coordinates the National Technical Working Group on Cancer Prevention, Early Detection & Screening.

Dr. Malenya holds a Master of Science in Global Health & Non-Communicable Diseases from University of Edinburgh.

Palliative Care Nurse and Counsellor

Gladys Nduku

Gladys is Palliative Care Nurse/Counselor, she holds a Bachelor of science in palliative care from Makerere university- Uganda and a post graduate diploma in palliative care from Cardiff University- UK. She holds a higher diploma in counseling psychology in medical health from Kenya Institute of psychological Counseling and a certificate in trainer of trainers (TOT) in End-of-life Nursing Continuum, Trained by the ELNC- USA.
Gladys has a vast amount of experience in palliative care and counseling after working in different departments of KNH.
She currently coordinates Palliative Care Services in the busy Pain & Palliative Care Unit, KNH after previously being involved in establishing and coordinating the successful Patient Navigation Program at Cancer Treatment Center -KNH, a program initiated by the American Cancer Society in partnership with KNH and has greatly improved patients experience and quality of life as they undergo cancer treatment.
Gladys is a co-founder and a former National treasurer of The Oncology Nurses chapter-Kenya.

Manager, Oncology Department

Dr Fredrick Asige

Dr Fredrick Asige is the Manager at the at The Nairobi Hospital, Oncology department since 2015 to date.
He attained his MPH from Suffolk University UK, BSc. in Health Systems Management at Kenya Methodist University and Diploma in Radiation Therapy at The Aga Khan University Hospital, Karachi, Pakistan. He also holds Diploma in Imaging sciences and Higher Diploma in Ultrasonography at the Kenya Medical Training college. He received his certificate training in Leadership and Management in Health, Project Management and Epidemiology at the University of Washington.
Before joining The Nairobi Hospital, he worked at The Aga Khan University Hospital Radiology department from as a radiographer from 2005-2008 then moved to pioneer its Radiotherapy department in 2011 after completing his training in Karachi. He thereafter moved to The Nairobi Hospital and was instrumental in establishing the state of the art Cancer Treatment Centre in 2012.
Mr. Fredrick Asige has been involved in various key policy issues pertinent to Cancer management both at private and public level through advisory, collaboration and partnerships between the private and public sectors in realizing Public Private Partnerships (PPP). He has been advocating through NHIF for access and coverage of patients seeking radiotherapy services to be cushioned from out-of-pocket payment.

Consultant Clinical Oncologist

Dr Abeid Athman

Abeid Omar is a consultant Clinical (medical and radiation) Oncologist and Nuclear Medicine based in Kilifi, Kenya. Besides, he consults for International Cancer Institute – ICI Eldoret, Kenya. He has keen interest in breast cancer in young women, oncofertility, breast cancer research, radiotherapy, advocacy and Global Oncology particularly in LMIC.

Dr. Abeid completed his training in Clinical Oncology and Nuclear Medicine in Alexandria University, Egypt in 2021. He is a fellow of College of European School of Oncology (ESCO) and he has also successfully passed the ESMO exam to become a certified ESMO oncologist.

Dr. Abeid has conducted researches, presented abstracts in ESMO, ASCO, ESTRO, St. Gallen, KESHO conferences and Aga Khan Symposium, published in peer reviewed journals about breast cancer in young women, pregnancy associated breast cancer, pregnancy after breast cancer among others under the close guidance of Prof. Hatem Azim, who has been mentoring him since 2019.

Dr. Abeid is an active member of several societies including KESHO – where he also serves as a member of the Education Committee, ASCO, ESMO, ESCO, Society of Toxicology. In 2019 he was awarded the ASCO Virtual Mentorship Program and currently he is under the mentorship of College of European School of Oncology. Besides, Dr. Abeid serves as a reviewer for several journals.

Executive Director, Kenya Hospices and Palliative Care Association (KEHPCA)

Mackuline Atieno

Mackuline is a Palliative Care Nurse and Medical Anthropologist with over 12 years’ experience in palliative care development. She is passionate about improving health outcomes through research and evidence based practice; and use of technology.

Before Joining KEHPCA, Mackuline worked with the African Palliative Care Association. She has provided technical support and management for more than 10 multi-partnership and multi-country projects in African countries including Botswana, Eswatini, Ghana, Malawi, Mozambique, Namibia, Rwanda, South Africa, Uganda, Zambia, Zimbabwe as well as Kenya.

She has been involved in palliative care policy reviews and development, research and development of palliative care information, education and communication materials and e learning at national and regional levels.

Mackuline holds a Bachelor’s Degree in Nursing, Diploma in Palliative Care, and is completing a Masters in Medical Anthropology.

Senior Lecturer and Specialist Physician

Dr Naftali Busakhala

Dr Naftali Busakhala is a senior lecturer and specialist physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects.

Dr Busakhala is a senior research fellow at the Institute of Prevention and Research, Lyon France.

He has published widely in peer reviewed journals.

He holds a Bachelor of Medicine and Surgery from Moi University. He holds a Pharmacology Certificate from Tianjin University China. He was a Fogarty trainee in Haematology and Oncology at Brown University, USA. He trained in Pharmacology and Therapeutics at the Makerere University.

Radiation Oncologist

Dr Jesse Opakas

Plenary Speakers

Consultant Clinical Oncologist, the Cancer Treatment Centre, Nairobi Hospital

Dr Njoki Njiraini

Consultant Medical Oncologist, Kenyatta National Hospital

Dr Sitna Ali Mwanzi

Director of Institute for Advanced Study of the Americas and Hemispheric & Global Affairs

Felicia Marie Knaul (MA, PhD)

MD, Medical Oncologist

Dr.Zilola Olimova

Chair in the department of clinical oncology Muhimbili University of Health and Allied Sciences (MUHAS).

Prof Twalib Ngoma

Surgeon-scientist with the Department of Surgery at Queen’s University

Dr. Sulaiman Nanji MD, PhD, FRCS, CIP

Head of City Hopsital Kiel Oncology Center and Professor of Internal Medicine (Hematology & Oncology) at the Christian-Albrechts-University of Kiel.

Prof Roland Repp

Professor of Cancer and Global Health at King’s College London and Guy’s Comprehensive Cancer Centre

Richard Sullivan

Professor at the Division of Medical Oncology, Queen's University, Kingston Health Science Center, Ontario, Canada

Nazik Hammad

Prof Mohsen Mokhtar

, MD, PhD is the Director of the Division of Human Health (NAHU) at the International Atomic Energy Agency (IAEA), Vienna, Austria

May Abdel-Wahab

MD, MPH, PGCert

Dr. Mary Nyangasi

Radiation Oncologist

Mary Gospodarowicz

Founding Chair, Department of Hematology – Oncology and Founding Director - AKU, N Cancer Center

Mansoor Saleh

Head of Radiation Oncology and Radiation Medicine at Groote Schuur Hospital and the University of Cape Town in South Africa

Jeannette Parkes

Medical Oncologist at the division of Medical and Radiation Oncology at Skåne University Hospital in Lund, Sweden

Gilberto Morgan

Medical Oncologist & Hematologist

Fredrick Chite

Professor of global health in Applied Physiology and Wellness and Anthropology, Southern Methodist University, Dallas Texas

Eric G. Bing

Medical Oncologist and an associate professor in medical oncology and public health sciences and scientist in the Division of Cancer Care and Epidemiology, in Queen’s University, Kingston, Canada

Bishal Gyawali

Senior clinical instructor in the Department of Pathology and Laboratory Medicine at the Aga Khan University Hospital

Allan Njau

Guy’s & St Thomas’ NHS Trust, London, UK London School of Hygiene and Tropical Medicine, UK

Dr Ajay Aggarwal

Senior Clinical Sales Specialist

Agnieszka Grybos-Gajniak

Consultant Clinical Oncologist, the Cancer Treatment Centre, Nairobi Hospital

Dr Njoki Njiraini

Dr. Njoki Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital.

She has been key in instituting multidisciplinary meetings, problem oriented research in the department, and streamlining patient care within the oncology clinics in the public and private sector.

Dr. Njiraini holds a bachelor’s degree in Medicine and Surgery from the University of Nairobi, a Master’s Degree in Radiation Oncology from the University of Cape Town, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme.

Consultant Medical Oncologist, Kenyatta National Hospital

Dr Sitna Ali Mwanzi

Dr Sitna Ali Mwanzi is a consultant medical oncologist working at the Kenyatta National Hospital in Nairobi Kenya. She obtained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany. Her research interests include breast cancer, lung cancer, prostate cancer, chronic myeloid leukemia and cervical cancer. She is passionate about increasing health care workers and general public awareness about cancer, role of screening, early diagnosis and treatment of cancer. She works closely with the National Cancer Control Program in implementation of the National Cancer Control Strategy and advising on cancer policy for improving access to cancer care.

Director of Institute for Advanced Study of the Americas and Hemispheric & Global Affairs

Felicia Marie Knaul (MA, PhD)

Felicia Marie Knaul (MA, PhD) has dedicated more than three decades to academic, advocacy, and policy work in global health and social development to reduce inequities focusing on low- and middle-income countries, particularly in Latin America. She currently serves as the Director of both the Institute for Advanced Study of the Americas and Hemispheric & Global Affairs; is Professor at the Miller School of Medicine; and is Member of Sylvester Comprehensive Cancer Center at the University of Miami.

She applies her knowledge as a health and social sector economist to closing the global cancer and pain divides and promoting access to palliative care, reducing the impact of child maltreatment, and promoting gender equity and health systems around UHC. To address these complex, global challenges, Knaul maintains a synergistic program of research and advocacy, including as Founding President of Tómatelo a Pecho, a Mexican NGO dedicated to reducing the impact of women´s cancers. She is also Co-Chair of the Lancet Commission on Cancer And Health Systems and the Lancet Commission on Gender-based Violence and Maltreatment of Young People, and serves as a Commissioner on the Lancet Breast Cancer Commission. She has authored nearly 300 journal publications and books, among them the report of the Lancet Commission on Global Access to Palliative Care and Pain Relief, which she chaired. As Director of the Harvard Global Equity Initiative (2009-15), she founded and directed the Global Task Force on Expanded Access to Cancer Care and Control, serving as lead author and co-editor of the task force’s publication Closing the Cancer Divide: An Equity Imperative (Harvard University Press/ Harvard Global Equity Initiative, 2012), and was a member of the Global Task Force on Radiotherapy for Cancer Control (GTFRCC) and co-author of the publication in Lancet Oncology. She lectures globally on the challenge of cancer in low- and middle-income countries, both as health systems researcher and patient-advocate, and has published a memoir describing her journey with breast cancer in Mexico.

MD, Medical Oncologist

Dr.Zilola Olimova

Chair in the department of clinical oncology Muhimbili University of Health and Allied Sciences (MUHAS).

Prof Twalib Ngoma

Prof. Twalib Athumani Ngoma currently holds a research chair in the department of clinical oncology Muhimbili University of Health and Allied Sciences (MUHAS). He is one of the authors and commissioners of the Lancet Oncology Commission Report of Cancer Control in sub-Sahara Africa which was published in May 2022. He is the founder of the Ocean Road Cancer Institute (ORCI) in Dar es Salaam Tanzania and was the Executive Director of ORCI from 1996 to 2014

Prof. Ngoma had his undergraduate MD training in the University of Dar es Salaam and post graduate training in Radiotherapy and Medical Oncology at the Christie Hospital in Manchester UK. He is a member of the Royal College of Radiologists UK and a Fellow of the faculty of Radiology Royal College Surgeons Ireland.

His research interests are in cancer control, palliative care and Global Health in which he has published more than sixty articles in peer-reviewed journals. He has also authored, co-authored and has written chapters in several books. His published books include State of Oncology in Africa, Emerging Models for Global Health, Global Burden of Cancer: Prevalence Pattern and Trends and Approaching Global Oncology: The win: win movement
Prof. Twalib Ngoma is a member of Tanzania Oncology Society, a member of American Society of Clinical Oncology (ASCO), and was the President of the Africa Organization for Research and Training in Cancer (AORTIC ) from 2007 to 2009. He has received several awards and honours including:

  • 2009 –International Network for Cancer Treatment and Research (INCTR) Nazli Gad el Mawla Award for outstanding contribution in cancer control in low resource environment
  • 2015 Harvard Global Health Catalyst award for outstanding contribution in cancer control globally
  • 2018 Internation Prevention Research Institute (iPRI) award for outstanding contribution in cancer control globally

He is married with five grown-up children, and 12 grandchildren.

Surgeon-scientist with the Department of Surgery at Queen’s University

Dr. Sulaiman Nanji MD, PhD, FRCS, CIP

Dr. Nanji is a surgeon-scientist with the Department of Surgery at Queen’s University. He has earned a MD, PhD, and designation as a clinical investigator through the Royal College of Physicians and Surgeons. He has dual fellowship accreditation in hepatobiliary and pancreatic surgery as well as multi-visceral organ transplantation. His clinical training and research interests have provided opportunities to work in several institutions including the Universities of British Columbia, Alberta and Toronto as well as Emory University, Kings College Hospital in London, UK and the National Aeronautics and Space Administration (NASA). His current research interests in oncology complement his clinical practice in the surgical treatment of hepatobiliary and pancreatic malignancies. He conducts translational research in the epigenetics of human liver cancer to better risk stratify and treat patients with liver cancer. He also conducts epidemiological and health services research in HPB malignancies through the Cancer Research Institute at Queen’s University. More recently, he is completing a Master’s degree in Global Surgery to advance his clinical and academic interests in global surgical development. Outside of his professional commitments, he enjoys playing guitar, martial arts and spending time outdoors with his wife and 3 children.

Head of City Hopsital Kiel Oncology Center and Professor of Internal Medicine (Hematology & Oncology) at the Christian-Albrechts-University of Kiel.

Prof Roland Repp

Prof. Repp obtained his medical degree from Friedrich-Alexander-University in Erlangen, Germany in 1990. He completed his residency and fellowship and worked as an senior physician in the Department of Medicine III at Erlangen University until 2004, where he also received his board certification for Internal Medicine and Hematology and Oncology. Until 2008, he was assistant professor at the Division of Stemcell-Transplantation and Immunotherapy at the Department of Medicine II, University Hospital of Schleswig-Holstein, Campus Kiel, Germany. He left to Bamberg, Germany in 2008 as Head of Department of Medicine V, Klinikum am Bruderwald, Sozialstiftung Bamberg, Bamberg, Germany, where he founded and directed the Cancer Center Bamberg. At that time he was also Deputy Director of the Comprehensive Cancer Center Erlangen-EMN. In 2016, he moved back to Kiel Germany as Head of Department of Internal Medicine 2 in the City Hopsital Kiel. He is the head of the hospital’s Oncology Center and Professor of Internal Medicine (Hematology & Oncology) at the Christian-Albrechts-University of Kiel.

His main basic and clinical research focus is on immunotherapy of cancer and clinical research in precision oncology. He also specialized in palliative medicine and is the chairman of the Board of the Hospice and Palliative Care Association of Schleswig-Holstein

Professor of Cancer and Global Health at King’s College London and Guy’s Comprehensive Cancer Centre

Richard Sullivan

Richard Sullivan is Professor of Cancer and Global Health at King’s College London and Guy’s Comprehensive Cancer Centre. He is director of the Institute of Cancer Policy and Director of the Centre for Conflict & Health Research at King’s. He is an NCD advisor to World Health Organisation and World Bank. His global cancer research programs cover cancer systems strengthening, financing, political economy, global cancer surgery partiuclarly virtual reality-enhanced surgical simulation training; as well as studies into social welfare and cancer care in conflict. He also directs a number of major research programs in conflict and health with a special focus on the Middle East, including Health Security Intelligence, Global Health Security and health systems strengthening in conflict. Professor Sullivan trained in surgery (urology) gaining his PhD in Biochemistry from University College London. Richard was formally Clinical Director of Cancer Research UK for nearly ten years and is a surgeon by background.

Professor at the Division of Medical Oncology, Queen's University, Kingston Health Science Center, Ontario, Canada

Nazik Hammad

Nazik Hammad is a Professor at the Division of Medical Oncology, Queen’s University, Kingston Health Science Center, Ontario, Canada. She is the Chair of the Education and Training Committee of the African Organization in Research and Training in Cancer (AORTIC). Prof. Hammad is a visiting professor at the University of Nairobi, Kenya. She is the co-chair of the Network for Advancing Black Learners (Medical Students and Residents) in Ontario. She is the former Director of Global Health, Faculty of Health Sciences at Queen’s University. She is an executive member of the Global Oncology Program at Queen’s University. She treats GI, breast and brain tumours.

Prof. Hammad has a keen interest in medical education, in particular health professions education in low and –middle-income countries (LMIC) and cancer workforce development. She has a Master degree in Medical Education in the Health Professions (MEHP) from Johns Hopkins University. She teaches regularly at the Clinical Oncology Training Program in Khartoum, Sudan and as a visiting professor at the Medical Oncology Fellowship Training Program, University of Nairobi, Kenya.

Her areas of expertise include training program development and evaluation, accreditation, curriculum development, mentoring and innovations in education. Her work on education has been presented at international conferences and published in peer-reviewed journals. She is a recipient of several grants in education including the Royal College of Physicians and Surgeons of Canada International Development, Aid and Collaboration Grant in 2020 for Faculty Development among African Oncologists. Her other areas of interest include value in cancer care. Together with colleagues in African she led the first Choosing Wisely Africa that was recently published in the Journal of Global Oncology.

Prof Mohsen Mokhtar

Prof Mohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses.

Prof Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE.

Prof Mokhtar has published more than 50 articles in several regional magazines in topics including: breast, lung, pediatric, colorectal, ovarian malignancies NHL and hematologic malignancies. Professionally, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities.

, MD, PhD is the Director of the Division of Human Health (NAHU) at the International Atomic Energy Agency (IAEA), Vienna, Austria

May Abdel-Wahab

May Abdel-Wahab, MD, PhD is the Director of the Division of Human Health (NAHU) at the International Atomic Energy Agency (IAEA), Vienna, Austria.
She has over 30 years of patient care, teaching, and research experience in the field of radiation oncology, specializing in treatment of prostate and gastrointestinal cancers. Her main areas of general focus include healthcare access and training, as well as novel solutions to address disparity and diversity issues. She has served as a member and chair, on various National and International committees, including the United Nations Interagency Task Force Steering committee (UNIATF) on Prevention and Control of Non-Communicable Diseases (NCDs), which coordinates UN-wide activities in NCDs.

She is a member of the UN Joint Programme on the Cervical Cancer Control Steering Committee, working at the global and national level with participating countries to support a national comprehensive cervical cancer control programme. She is co-lead author on the Lancet Oncology Commission report on Imaging and Nuclear Medicine, studying cost and access in oncology. She has served as chair of the ASTRO Committee for Healthcare Access & Training and Co-Chair of the Integration of Health Enterprise in Radiation Oncology (IHE-RO) Planning Committee, working on interconnectivity issues at various levels of patient care.

Dr. Wahab has been an avid lecturer and participant on scientific panels. She has also served on expert panels for treatment guidelines and published widely. She has a particular interest in education and curriculum development as a former Residency Program Director and has organized numerous symposia and scientific meetings. She has also served on advisory boards, expert panels, and professional journal editorial boards. She was Principal Investigator on Phase I and Phase II clinical trials and studied the interaction of novel GHRH-antagonists and radiation in her lab in close collaboration with Dr. Andrew Schally’s lab.

Prior to joining IAEA, she was section head of GI Radiation Oncology at the Cleveland Clinic, USA, and Professor at the Cleveland Clinic Lerner School of Medicine, Case Western University. Her research also focused on prostate and GI cancers as well as quality assurance and safety and access to radiotherapy. She is a fellow of both the American Board of Radiology (ACR) and the American Society of Radiation Oncology (ASTRO) and was featured on the Best Doctors in America listing, among other honors.

MD, MPH, PGCert

Dr. Mary Nyangasi

Head of the National Cancer Control Program, Ministry of Health of Kenya. She has been instrumental in leading the formulation of Kenya’s cancer policy and implementation of the National Cancer Control Strategy 2017-2022. A global health physician with 15-year career experience spanning clinical and policy areas. She has led the scale up of the cervical cancer screening program and establishment of breast cancer screening program, regional cancer treatment centers and access to cancer medicines in Kenya. She has published in various peer-reviewed journals and is a member of KESHO, AORTIC and the Kenya Red Cross. A WomenLiftHealth 2022 Fellow, Dr. Nyangasi is a member of the Steering Committees for International Cancer Control Planning and the Cancer Care Africa.

Radiation Oncologist

Mary Gospodarowicz

Mary Gospodarowicz, University Professor at the University of Toronto and past director of the Princess Margaret Cancer Centre is a radiation oncologist with longstanding interest in clinical research in genitourinary cancers and lymphomas. Her current interests include global cancer control, global access to radiotherapy, and technology innovation. Dr. Gospodarowicz is a Past-President of UICC where she continues to co-chair the TNM and Prognostic Factors Project. She initiated the Lancet Oncology Commission on Radiotherapy and currently co-chairs the Lancet Commission on Cancer and Health Systems.

Founding Chair, Department of Hematology – Oncology and Founding Director - AKU, N Cancer Center

Mansoor Saleh

Mansoor Saleh, MD received his early education in the Aga Khan School system in East Africa, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg. He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program. His area of research and clinical focus is
“targeted therapy of cancer”. In January 2020, he joined the Aga Khan University in Nairobi, Kenya as the Founding Chair, Department of Hematology – Oncology and Founding Director – AKU, N Cancer Center.

Head of Radiation Oncology and Radiation Medicine at Groote Schuur Hospital and the University of Cape Town in South Africa

Jeannette Parkes

Jeannette Parkes is Head of Radiation Oncology and Radiation Medicine at Groote Schuur Hospital and the University of Cape Town in South Africa. Her clinical portfolio includes management of CNS tumours, bone and soft tissue tumours and paediatric radiotherapy.

Internationally, she is LMIC representative on the executive committee of the Paediatric Radiation Oncology Society(PROS), and has been a team leader of SIOP Global Health network’s PROS LMIC working group since 2016. She is the radiotherapy representative on SIOP Africa’s executive committee, as well as SNOSSA(Society of neuro-oncology in Sub-Saharan Africa) executive committee.

She has contributed to the WHO working groups for the technical package associated with the Global Initiative for Childhood Cancer(GICC) and has contributed to several international adapted treatment guidelines for treatment of Paediatric cancer in low and middle income countries. She is editor of the IAEA guideline for paediatric radiation oncology, and has acted as PROS/ARIA coordinator and now chairperson of the ARIA AMG(adapted management guideline) steering committee.

Medical Oncologist at the division of Medical and Radiation Oncology at Skåne University Hospital in Lund, Sweden

Gilberto Morgan

Gilberto Morgan, MD is a medical oncologist at the division of Medical and Radiation Oncology at Skåne University Hospital in Lund, Sweden. He is a clinician and researcher with a background in molecular biology. A product of the University of Texas educational system, Dr. Morgan was a fellow at the National Institutes of Health in Bethesda, Maryland in developmental and molecular biology, and after his medical education he developed a strong interest in the field of cancer prevention and received training at the National Cancer Institute in Maryland and at the MD Anderson Cancer Center in Houston, Texas.

Dr. Morgan is in the editorial team of ESMO Open Cancer Horizons, Critical reviews in Oncology & Haematology, and the Journal of Immunotherapy and Precision Oncology, and serves as member of the eESO advisory board for the European School of Oncology.

He is the creator and director of the OncoAlert network, which aims to promote oncology education through social media and is an ongoing collaborator with ESMO.

Dr. Morgan is the current Chair of the ESMO Social Media Working Group and has previously served on the ESMO Membership Committee for four years. As of the beginning of 2021 Dr. Morgan is a member of the ESMO European Policy Committee and the ESMO Global Policy Committee, which address political topics of concern to ESMO and its members at the European and global levels. He is passionate about promoting good practice and eliminating discrepancies in the quality of cancer care. He was also a member of the ESMO Faculty Group for Cancer Prevention in 2019 and in the same year was chosen by ESMO as a participant of the 2019 ESMO Leaders Generation Programme.

Medical Oncologist & Hematologist

Fredrick Chite

Prof. Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, an organization whose main purpose is to expand Education, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs.

He is a Medical Oncologist & Hematologist, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program (Kenya, Rwanda, Tanzania and Uganda), Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics & therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program, Oncology Pharmacy program and assisted in the development of gynecologic oncology program. He also conducts Oncology and Hematology Clinical Trials in SSA.

He was previously (2011-2019), the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya. In this role he developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Breast Cancer screening & treatment program, Hemophilia and Sickle cell diagnostics, treatment & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program, MLCCP (Kenya, South Africa, Lesotho, Tanzania, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) of various Oncology Clinical Trial Centers in SSA.

He has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC), International Affairs Committee (IAC), Education Council, ASCO‘s Academic Global Oncology Task Force and as a Peer reviewer to ASCO Journals. He is also currently a member of ASCO-ESMO Global Oncology Curriculum committee and a member of ASCO’s board of directors. He has been recognized for his work to increase access to cancer control for the underserved through various awards including the United States’ National Cancer Institute’s Pearline Global Cancer Research Humanitarian Award, 2020; The Children’s Place International ‘s 2018 Hero Award for his pioneering work in treating children and adults with cancers in Kenya. He is the current Interim President of the College of Oncology of East, Central and Southern Africa (ECSA-CO) and a senate member for ECSA Health Community. He is also a distinguished Faculty speaker in both local, regional and International professional conferences and events including ASCO, AORTIC, KESHO, Africa Cancer ECHO, APCA amongst others.

He did his Undergraduate training (Bachelor of Medicine and Bachelor of Surgery) in Kenya and Post-graduate/specialty training (Internal Medicine Residency & Heme/Onc Fellowship) in the United States.

Professor of global health in Applied Physiology and Wellness and Anthropology, Southern Methodist University, Dallas Texas

Eric G. Bing

Dr. Eric Gordon Bing is a professor of global health in Applied Physiology and Wellness and Anthropology at Southern Methodist University in Dallas Texas. As the founding director of two institutions at SMU, Eric leads the interdisciplinary research, services and education efforts at SMU to help deliver effective, acceptable, and affordable health solutions to those who need them most. The current focus on his research is improving provider skills using immersive virtual reality. He co-directs SMU recruitment efforts for research in Technology-enhanced Immersive Learning (TEIL). TEIL uses technology as a research tool to improve outcomes in education, health and society through Immersive Learning and Artificial Intelligence. Learn more at https://www.smu.edu/TEIL.

Dr. Bing was the senior fellow and founding director of global health at the George W. Bush Institute (2011-2015) where he co-led the institute’s Pink Ribbon Red Ribbon partnership, an $85 million public-private program designed to combat cervical and breast cancer. He received his medical degree from Harvard Medical School, a Master’s of Public Health and a PhD in Epidemiology from UCLA, and an MBA from the Fuqua School of Business at Duke University.

Medical Oncologist and an associate professor in medical oncology and public health sciences and scientist in the Division of Cancer Care and Epidemiology, in Queen’s University, Kingston, Canada

Bishal Gyawali

Bishal Gyawali, MD, PhD is a medical oncologist and an associate professor in medical oncology and public health sciences and scientist in the Division of Cancer Care and Epidemiology, in Queen’s University, Kingston, Canada. He did his cancer policy fellowship at Harvard Medical School and previously served as a medical consultant for the not-for-profit Anticancer Fund, before joining Queen’s. His clinical expertise is across multiple adult solid tumors, with special focus on GI, GU and breast malignancies. He is in the editorial and advisory board for multiple medicine and oncology journals and has authored or co-authored more than 150 peer-reviewed articles in high-impact journals. Dr. Gyawali’s areas of academic interests include cancer policy, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, supportive care, cancer care disparities, and global oncology. He introduced the term “cancer groundshot” and chaired a session on the same at ASCO 2022. His interviews and studies have been reported in several influential media such as CNN, NPR, Washington Post, STAT News etc. He is an expert for the WHO Drug Advisory Panel. He is a member of the WHO Essential Medicines List Committee for cancer drugs, ESMO-MCBS and ESMO Global Policy committees, and ASCO-Health Equity and Outcomes Committee.

Senior clinical instructor in the Department of Pathology and Laboratory Medicine at the Aga Khan University Hospital

Allan Njau

Dr. Allan Njau is a senor clinical instructor in the department of Pathology and Laboratory Medicine at the Aga Khan University Hospital, Nairobi, Kenya. He holds a bachelor’s degree in Medicine and Surgery from the University of Nairobi (2008), Master of medicine in Anatomic Pathology from the Aga Khan University (2016) and a fellowship in Molecular Pathology from Augusta University, GA, USA (2020). His roles include clinical service in the Anatomic Pathology and Molecular Pathology sections of the institution as well as teaching. His interests are in the fields of molecular assays especially for oncology testing, bioinformatics and artificial intelligence applications in molecular pathology, laboratory management and hepatobiliary pathology. His past and current research engagements are in the areas of pathology informatics, Acute myeloid leukemia, endometrial carcinoma, extrapulmonary tuberculosis, COVID-19, gastric cancer and Helicobacter pylori infections. He is a member of the Association for Molecular Pathology and American Association of Cancer Research.

Guy’s & St Thomas’ NHS Trust, London, UK London School of Hygiene and Tropical Medicine, UK

Dr Ajay Aggarwal

Dr Ajay Aggarwal is a Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Trust, London and Associate Professor at the London School of Hygiene and Tropical Medicine (LSHTM). His main research areas are health system design, performance assessment of cancer care and Global Health. He was awarded an Advanced Fellowship by the National Institute for Health Research (NIHR) in 2020 and is the current editor of the Journal of Cancer Policy. In his role as the Oncology Coordinator for the UK National Prostate Cancer Audit, he co-led the development and delivery of the first ever national hospital outcome reporting programme for radiotherapy. His research has contributed significantly to national and international policy discussion around the affordability of cancer care and the value of new technologies in cancer medicine which has directly influenced the WHO Cancer Drug Pricing and Benefits Taskforces. As co-chair of the Health Economics in Radiation Oncology (HERO) group within ESTRO (European Society for Radiation Oncology), he is co-leading the value-based health care initiative. He has previously worked at the World Health Organisation in Geneva and I am the Chief Investigator of the NIH funded ARCHERY study, the first prospective international multicentre trial across India, Jordan, Malaysia and South Africa evaluating the role of AI in radiotherapy.

Senior Clinical Sales Specialist

Agnieszka Grybos-Gajniak

Agnieszka Grybos-Gajniak is a Senior Clinical Sales Specialist and has joined Illumina in 2016. After completing her degree in Biotechnology, she worked for various companies providing solutions for cancer research and diagnostics. Prior to her current position she was part of Oncology team supporting Illumina’s oncology NGS panels across Europe, Middle East and Africa.

Registration Packages

CategoryEarly Bird
( From 30th July 2022 )
Late Bird
( From 30th August 2022 )
Onsite
KESHO MembersKSH 15,500KSH 18,500KSH 25,500
International Delegates( Outside Africa)$350$350$450
Delegates from Africa$250$250$300
Non-KESHO physicians, Consultants, PHDKSH 22,500KSH 22,500KSH 30,000
Nurses, allied professionals, RegistrarsKSH 14,500KSH 16,500KSH 20,000
Undergraduate StudentsKSH 9,000KSH 10,000KSH 10,500
Single Day RateKSH 10,000KSH 10,000KSH 10,000

Please note that registration fees do not cover transport or accommodation.

Venue

Sarova Whitesands Hotel is amongst the best beachfront hotels in Mombasa offering world class facilities and activities to corporate travellers. Half an hour from Mombasa’s city centre and 21 kilometres from Mombasa’s Moi International Airport, Sarova Whitesands is the ideal place to host large meetings at an international standard. The hotel is defined by its modern design, advanced accommodation and conferencing facilities and exceptional radiant services all tempered with a vibrant mix of art and colour. And with its high speed WiFi that is available throughout the hotel several other pros, Sarova Whitesands was unanimously approved as the home for the 2022 KICC.
Please select your preferred hotel from the options provided and make your reservations directly with the hotel.

Programme at a glance

Find programme schedule for KICC 2022

Become a sponsor

Sponsoring and exhibiting at the Conference will give your organization a unique opportunity to promote your brand and key messages to delegates from a wide range of backgrounds, expertise and influence across the continent. You will have extensive marketing exposure in the lead-up to the event as well as during the conference.

For further details on sponsorship and exhibitor categories please contact the Secretariat: secretariat@kesho-kenya.org

2022 KICC Sponsors



Our 2022 Partners

Ministry of Health Logo

KEHPCA Logo

Oncology Nurses Chapter Kenya

Oncology Nurses Chapter Kenya